Bienaime Jean Jacques

DirectorAscendis Pharma A/S (ASND) · full profile →Form 4 · filed Aug 19, 2026
Net Buying
Open-Market Buys
$493K
Open-Market Sells
$0
Net Open-Market Flow
$493K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 14, 2026Buy(P)1K$245.85$270K2K
Aug 14, 2026Buy(P)900$246.91$222K3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000360) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.